Book contents
- High-Risk Pregnancy: Management Options
- High-Risk Pregnancy: Management Options
- Copyright page
- Contents
- Contributors
- Section 1 Prepregnancy Problems
- Section 2 Early Prenatal Problems
- Section 3 Late Prenatal – Fetal Problems
- Section 4 Problems Associated with Infection
- Chapter 24 Hepatitis Virus Infections in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 25 Human Immunodeficiency Virus in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 26 Rubella, Measles, Mumps, Varicella, and Parvovirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 27 Cytomegalovirus, Herpes Simplex Virus, Adenovirus, Coxsackievirus, and Human Papillomavirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 28 Parasitic Infections in Pregnancy (Content last reviewed: 15th June 2018)
- Chapter 29 Other Infectious Conditions in Pregnancy (Content last reviewed: 11th November 2020)
- Section 5 Late Pregnancy – Maternal Problems
- Section 6 Late Prenatal – Obstetric Problems
- Section 7 Postnatal Problems
- Section 8 Normal Values
- Index
- References
Chapter 29 - Other Infectious Conditions in Pregnancy (Content last reviewed: 11th November 2020)
Published online by Cambridge University Press: 15 November 2017
Book contents
- High-Risk Pregnancy: Management Options
- High-Risk Pregnancy: Management Options
- Copyright page
- Contents
- Contributors
- Section 1 Prepregnancy Problems
- Section 2 Early Prenatal Problems
- Section 3 Late Prenatal – Fetal Problems
- Section 4 Problems Associated with Infection
- Chapter 24 Hepatitis Virus Infections in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 25 Human Immunodeficiency Virus in Pregnancy (Content last reviewed: 23rd July 2019)
- Chapter 26 Rubella, Measles, Mumps, Varicella, and Parvovirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 27 Cytomegalovirus, Herpes Simplex Virus, Adenovirus, Coxsackievirus, and Human Papillomavirus in Pregnancy (Content last reviewed: 11th November 2020)
- Chapter 28 Parasitic Infections in Pregnancy (Content last reviewed: 15th June 2018)
- Chapter 29 Other Infectious Conditions in Pregnancy (Content last reviewed: 11th November 2020)
- Section 5 Late Pregnancy – Maternal Problems
- Section 6 Late Prenatal – Obstetric Problems
- Section 7 Postnatal Problems
- Section 8 Normal Values
- Index
- References
Summary
Infections are an important contributor to maternal and perinatal morbidity and mortality rates. The relative immunosuppression that occurs during pregnancy may alter the natural course of many infectious diseases. Higher attack rates for a variety of bacterial and viral infections are seen in pregnancy. Furthermore, many of these infections may be associated with adverse outcomes, including preterm labor and delivery, low birth weight, and stillbirth. This chapter addresses a large group of infectious diseases and conditions not discussed in other chapters, including streptococcal infections, listeriosis, common sexually transmitted infections (STIs), and vaginitis.
- Type
- Chapter
- Information
- High-Risk PregnancyManagement Options, pp. 728 - 778Publisher: Cambridge University PressFirst published in: 2017
References
Further Reading
Brocklehurst, P, Gordon, A, Heatley, E, Milan, SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013; (1): CD000262.
Centers for Disease Control and Prevention (CDC). Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae: 2014. MMWR Recomm Rep 2014; 63 (RR-02): 1–19.
Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61: 590–4.
Lamont, RF, Sobel, J, Mazaki-Tovi, S, et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med 2011; 39: 227–36.
Liu, C, Bayer, A, Cosgrove, SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18–55.
Sheffield, JS. Methicillin-resistant Staphylococcus aureus in obstetrics. Am J Perinatol 2013; 30: 125–9.
Stevens, DL. The flesh-eating bacterium: what’s next? J Infect Dis 1999; 179 (Suppl 2): S366–74.
Verani, JR, McGee, L, Schrag, SJ. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1–36.
Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269: 390–1.
Workowski, KA, Berman, SM. Centers for Disease Control and Prevention sexually transmitted disease treatment guidelines. Clin Infect Dis 2011; 53 (Suppl 3): S59–63.
References
Adriaanse, AH, Pel, M, Bleker, OP. Semmelweis: the combat against puerperal fever. Eur J Obstet Gynecol Reprod Biol 2000; 90: 153–8.
Cunningham, MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470–511.
Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269: 390–1.
Lancefield, RC. A serologic differentiation of human and other groups of hemolytic streptococci A. J Exp Med 1933; 57: 571–95.
Efstratiou, A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45 (Suppl): 3–12.
Bannan, J, Visvanathan, K, Zabriskie, JB. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Infect Dis Clin North Am 1999; 13: 387–96, ix.
Stevens, DL. The flesh-eating bacterium: what’s next? J Infect Dis 1999; 179 (Suppl 2): S366–74.
Chuang, I, Van Beneden, C, Beall, B, Schuchat, A. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995–2000. Clin Infect Dis 2002; 35: 665–70.
Barnham, MR, Weightman, NC. Bacteraemic Streptococcus pyogenes infection in the peri-partum period: now a rare disease and prior carriage by the patient may be important. J Infect 2001; 43: 173–6.
Deutscher, M, Lewis, M, Zell, ER, et al. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011; 53: 114–23.
Greenberg, D, Leibovitz, E, Shinnwell, ES, Yagupsky, P, Dagan, R. Neonatal sepsis caused by Streptococcus pyogenes: resurgence of an old etiology? Pediatr Infect Dis J 1999; 18: 479–81.
Verboon-Maciolek, MA, Krediet, TG, van Ertbruggen, I, Gerards, LJ, Fleer, A. Severe neonatal group A streptococcal disease. Eur J Pediatr 2000; 159: 450–2.
Panaro, NR, Lutwick, LI, Chapnick, EK. Intrapartum transmission of group A streptococcus. Clin Infect Dis 1993; 17: 79–81.
Stevens, DL, Tanner, MH, Winship, J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1–7.
Mead, PB, Winn, WC. Vaginal–rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol 2000; 8: 217–19.
Stefonek, KR, Maerz, LL, Nielsen, MP, Besser, RE, Cieslak, PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. Obstet Gynecol 2001; 98: 846–8.
Okumura, K, Schroff, R, Campbell, R, Nishioka, L, Elster, E. Group A streptococcal puerperal sepsis with retroperitoneal involvement developing in a late postpartum woman: case report. Am Surg 2004; 70: 730–2.
Stevens, DL, Gibbons, AE, Bergstrom, R, Winn, V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158: 23–8.
Norrby-Teglund, A, Kaul, R, Low, DE, McGeer, A, Andersson, J, Andersson, U, et al. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect Immun 1996; 64: 5395–8.
Linner, A, Darenberg, J, Sjolin, J, Henriques-Normark, B, Norrby-Teglund, A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 2014; 59: 851–7.
Eickhoff, TC, Klein, JO, Daly, AK, Ingall, D, Finland, M. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. N Engl J Med 1964; 271: 1221–8.
American College of Obstetrics and Gynecologists. ACOG Committee Opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173: June 1996. Committee on Obstetric Practice. Int J Gynaecol Obstet 1996; 54: 197–205.
Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996; 45 (RR-7): 1–24.
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997; 99: 489–96.
Schrag, S, Gorwitz, R, Fultz-Butts, K, Schuchat, A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51 (RR-11): 1–22.
Verani, JR, McGee, L, Schrag, SJ. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1–36.
American College of Obstetricians and Gynecologists. Prevention of group B Streptococcal early-onset disease in newborns. ACOG Committee Opinion No. 797, February 2020. www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/02/prevention-of-group-b-streptococcal-early-onset-disease-in-newborns (accessed August 2020).
Regan, JA, Klebanoff, MA, Nugent, RP, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996; 174: 1354–60.
Turrentine, MA, Ramirez, MM. Recurrence of group B streptococci colonization in subsequent pregnancy. Obstet Gynecol 2008; 112: 259–64.
Hoogkamp-Korstanje, JA, Gerards, LJ, Cats, BP. Maternal carriage and neonatal acquisition of group B streptococci. J Infect Dis 1982; 145: 800–3.
Baker, CJ, Edwards, MS, Kasper, DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981; 68: 544–9.
Blanco, JD, Gibbs, RS, Castaneda, YS. Bacteremia in obstetrics: clinical course. Obstet Gynecol 1981; 58: 621–5.
Anderson, BL, Simhan, HN, Simons, KM, Wiesenfeld, HC. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am J Obstet Gynecol 2007; 196: 524.e1–5.
Romero, R, Mazor, M, Oyarzun, E, et al. Is there an association between colonization with group B streptococcus and prematurity? J Reprod Med 1989; 34: 797–801.
Moller, M, Thomsen, AC, Borch, K, Dinesen, K, Zdravkovic, M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984; 2: 69–70.
Thomsen, AC, Morup, L, Hansen, KB. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet 1987; 1: 591–3.
Schrag, SJ, Zywicki, S, Farley, MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15–20.
Jamie, WE, Edwards, RK, Duff, P. Vaginal–perianal compared with vaginal–rectal cultures for identification of group B streptococci. Obstet Gynecol 2004; 104: 1058–61.
Orafu, C, Gill, P, Nelson, K, Hecht, B, Hopkins, M. Perianal versus anorectal specimens: is there a difference in Group B streptococcal detection? Obstet Gynecol 2002; 99: 1036–9.
Price, D, Shaw, E, Howard, M, et al. Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial. J Obstet Gynaecol Can 2006; 28: 1083–8.
Yancey, MK, Armer, T, Clark, P, Duff, P. Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 1992; 80: 1038–47.
Walker, CK, Crombleholme, WR, Ohm-Smith, MJ, Sweet, RL. Comparison of rapid tests for detection of group B streptococcal colonization. Am J Perinatol 1992; 9: 304–8.
Honest, H, Sharma, S, Khan, KS. Rapid tests for group B streptococcus colonization in laboring women: a systematic review. Pediatrics 2006; 117: 1055–66.
Aziz, N, Baron, EJ, D’Souza, H, et al. Comparison of rapid intrapartum screening methods for group B streptococcal vaginal colonization. J Matern Fetal Neonatal Med 2005; 18: 225–9.
Rallu, F, Barriga, P, Scrivo, C, Martel-Laferriere, V, Laferriere, C. Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women. J Clin Microbiol 2006; 44: 725–8.
Gavino, M, Wang, E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol 2007; 197: 388.e1–4.
Edwards, RK, Novak-Weekley, SM, Koty, PP, et al. Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet Gynecol 2008; 111: 1335–41.
Boyer, KM, Gadzala, CA, Burd, LI, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983; 148: 795–801.
Boyer, KM, Gotoff, SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 1985; 35: 267–80.
Allardice, JG, Baskett, TF, Seshia, MM, Bowman, N, Malazdrewicz, R. Perinatal group B streptococcal colonization and infection. Am J Obstet Gynecol 1982; 142: 617–20.
Boyer, KM, Gotoff, SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665–9.
Morales, WJ, Lim, DV, Walsh, AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986; 155: 979–83.
Morales, WJ, Lim, D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987; 157: 13–16.
Tuppurainen, N, Hallman, M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989; 73: 583–7.
Matorras, R, Garcia-Perea, A, Omenaca, F, et al. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991; 40: 57–62.
Garland, SM, Fliegner, JR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol 1991; 31: 119–22.
Allen, UD, Navas, L, King, SM. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. CMAJ 1993; 149: 1659–65.
Schrag, SJ, Zell, ER, Lynfield, R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233–9.
de Cueto, M, Sanchez, MJ, Sampedro, A, et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998; 91: 112–14.
Lin, FY, Brenner, RA, Johnson, YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001; 184: 1204–10.
Phares, CR, Lynfield, R, Farley, MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 2008; 299: 2056–65.
Baker, CJ, Paoletti, LC, Wessels, MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999; 179: 142–50.
Baker, CJ, Paoletti, LC, Rench, MA, et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis 2000; 182: 1129–38.
Kasper, DL, Paoletti, LC, Wessels, MR, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996; 98: 2308–14.
Kobayashi, M, Schrag, SJ, Alderson, MR, et al. WHO consultation on group B Streptococcus vaccine development: report from a meeting held on 27–28 April 2016. Vaccine 2016; pii: S0264-410X(16)31236-1. doi: 10.1016/j.vaccine.2016.12.029.
Gorwitz, RJ, Kruszon-Moran, D, McAllister, SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis 2008; 197: 1226–34.
Andrews, JI, Shamshirsaz, AA, Diekema, DJ. Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus. Obstet Gynecol 2008; 112: 933–8.
Andrews, WW, Schelonka, R, Waites, K, et al. Genital tract methicillin-resistant Staphylococcus aureus: risk of vertical transmission in pregnant women. Obstet Gynecol 2008; 111: 113–18.
Chen, KT, Huard, RC, Della-Latta, P, Saiman, L. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol 2006; 108: 482–7.
Gray, JW, Suviste, J. Three years’ experience of screening for meticillin-resistant Staphylococcus aureus in obstetrics. J Hosp Infect 2013; 83: 61–3.
Liu, C, Bayer, A, Cosgrove, SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52: 285–92.
Liu, C, Bayer, A, Cosgrove, SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18–55.
Sheffield, JS. Methicillin-resistant Staphylococcus aureus in obstetrics. Am J Perinatol 2013; 30: 125–9.
Branch-Elliman, W, Lee, GM, Golen, TH, et al. Health and economic burden of post-partum Staphylococcus aureus breast abscess. PloS One 2013; 8 (9): e73155.
Silver, HM. Listeriosis during pregnancy. Obstet Gynecol Surv 1998; 53: 737–40.
Adams, DA, Thomas, KR, Jajosky, RA, et al. Summary of notifiable infectious diseases and conditions: United States, 2014. MMWR Morb Mortal Wkly Rep 2016; 63 (54): 1–152.
Silk, BJ, Date, KA, Jackson, KA, et al. Invasive listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004–2009: further targeted prevention needed for higher-risk groups. Clin Infect Dis 2012; 54 (Suppl 5): S396–404.
Southwick, FS, Purich, DL. Intracellular pathogenesis of listeriosis. N Engl J Med 1996; 334: 770–6.
Rappaport, F, Rabinovitz, M, Toaff, R, Krochik, N. Genital listeriosis as a cause of repeated abortion. Lancet 1960; 1: 1273–5.
Macnaughton, MC. Listeria monocytogenes in abortion. Lancet 1962; 2: 484–6.
Ansbacher, R, Borchardt, KA, Hannegan, MW, Boyson, WA. Clinical investigation of Listeria monocytogenes as a possible cause of human fetal wastage. Am J Obstet Gynecol 1966; 94: 386–90.
Lawler, FC, Wood, WS, King, S, Metzger, WI. Listeria monocytogenes as a cause of fetal loss. Am J Obstet Gynecol 1964; 89: 915–23.
Elinav, H, Hershko-Klement, A, Valinsky, L, et al. Pregnancy-associated listeriosis: clinical characteristics and geospatial analysis of a 10-year period in Israel. Clin Infect Dis 2014; 59: 953–61.
Mascola, L, Ewert, DP, Eller, A. Listeriosis: a previously unreported medical complication in women with multiple gestations. Am J Obstet Gynecol 1994; 170: 1328–32.
Mylonakis, E, Paliou, M, Hohmann, EL, Calderwood, SB, Wing, EJ. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine 2002; 81: 260–9.
McLauchlin, J. Human listeriosis in Britain, 1967–85, a summary of 722 cases. 1. Listeriosis during pregnancy and in the newborn. Epidemiol Infect 1990; 104: 181–9.
Craig, S, Permezel, M, Doyle, L, Mildenhall, L, Garland, S. Perinatal infection with Listeria monocytogenes. Aust N Z J Obstet Gynaecol 1996; 36: 286–90.
Lamont, RF, Sobel, J, Mazaki-Tovi, S, et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med 2011; 39: 227–36.
Schlech, WF, Lavigne, PM, Bortolussi, RA, et al. Epidemic listeriosis: evidence for transmission by food. N Engl J Med 1983; 308: 203–6.
Linnan, MJ, Mascola, L, Lou, XD, et al. Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med 1988; 319: 823–8.
Gaulin, C, Ramsay, D, Bekal, S. Widespread listeriosis outbreak attributable to pasteurized cheese, which led to extensive cross-contamination affecting cheese retailers, Quebec, Canada, 2008. J Food Prot 2012; 75: 71–8.
Tappero, JW, Schuchat, A, Deaver, KA, Mascola, L, Wenger, JD. Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA 1995; 273: 1118–22.
Centers for Disease Control and Prevention (CDC). Multistate outbreak of listeriosis associated with Jensen Farms cantaloupe: United States, August-September 2011. Morb Mortal Wkly Rep 2011; 60: 1357–8
American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Obstet Gynecol 2014; 124: 1241–4.
Cruikshank, DP, Warenski, JC. First-trimester maternal Listeria monocytogenes sepsis and chorioamnionitis with normal neonatal outcome. Obstet Gynecol 1989; 73: 469–71.
Fleming, AD, Ehrlich, DW, Miller, NA, Monif, GR. Successful treatment of maternal septicemia due to Listeria monocytogenes at 26 weeks’ gestation. Obstet Gynecol 1985; 66 (3 Suppl): 52S–53S.
Charles, AG, Cohen, S, Kass, MB, Richman, R. Asymptomatic gonorrhea in prenatal patients. Am J Obstet Gynecol 1970; 108: 595–9.
Spence, MR. Gonorrhea in a military prenatal population. Obstet Gynecol 1973; 42: 223–6.
Kirkcaldy, RD, Harvey, A, Papp, JR, et al. Neisseria gonorrhoeae antimicrobial susceptibility surveillance: the Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ 2016; 65 (7): 1–19.
Corman, LC, Levison, ME, Knight, R, Carrington, ER, Kaye, D. The high frequency of pharyngeal gonococcal infection in a prenatal clinic population. JAMA 1974; 230: 568–70.
Holmes, KK, Counts, GW, Beaty, HN. Disseminated gonococcal infection. Ann Intern Med 1971; 74: 979–93.
Edwards, LE, Barrada, MI, Hamann, AA, Hakanson, EY. Gonorrhea in pregnancy. Am J Obstet Gynecol 1978; 132: 637–41.
Burkman, RT, Tonascia, JA, Atienza, MF, King, TM. Untreated endocervical gonorrhea and endometritis following elective abortion. Am J Obstet Gynecol 1976; 126: 648–51.
Miller, JM, Maupin, RT, Mestad, RE, Nsuami, M. Initial and repeated screening for gonorrhea during pregnancy. Sex Transm Dis 2003; 30: 728–30.
Centers for Disease Control and Prevention (CDC). Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae: 2014. MMWR Recomm Rep 2014; 63 (RR-02): 1–19.
Workowski, KA, Berman, SM. Centers for Disease Control and Prevention sexually transmitted disease treatment guidelines. Clin Infect Dis 2011; 53 (Suppl 3): S59–63.
Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61: 590–4.
Allen, VG, Mitterni, L, Seah, C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013; 309: 163–70.
Johnson, NB, Hayes, LD, Brown, K, Hoo, EC, Ethier, KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors: United States, 2005–2013. MMWR Suppl 2014; 63 (4): 3–27.
Hardy, PH, Hardy, JB, Nell, EE, et al. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984; 2: 333–7.
Schachter, J, Grossman, M, Sweet, RL, et al. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255: 3374–7.
Sweet, RL, Landers, DV, Walker, C, Schachter, J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol 1987; 156: 824–33.
Johnson, NB, Hayes, LD, Brown, K, Hoo, EC, Ethier, KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors: United States, 2005–2013. MMWR Surveill Summ 2014; 63 (Suppl 4): 3–27.
Torrone, E, Papp, J, Weinstock, H. Prevalence of Chlamydia trachomatis genital infection among persons aged 14–39 years: United States, 2007–2012. MMWR Morb Mortal Wkly Rep 2014; 63: 834–8.
Baud, D, Greub, G. Intracellular bacteria and adverse pregnancy outcomes. Clin Microbiol Infect 2011; 17: 1312–22.
Martin, DH, Koutsky, L, Eschenbach, DA, et al. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA 1982; 247: 1585–8.
Gravett, MG, Nelson, HP, DeRouen, T, et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899–903.
Alger, LS, Lovchik, JC, Hebel, JR, Blackmon, LR, Crenshaw, MC. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 1988; 159: 397–404.
Wager, GP, Martin, DH, Koutsky, L, et al. Puerperal infectious morbidity: relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am J Obstet Gynecol 1980; 138: 1028–33.
Blas, MM, Canchihuaman, FA, Alva, IE, Hawes, SE. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect 2007; 83: 314–18.
Harrison, HR, Alexander, ER, Weinstein, L, et al. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy: epidemiology and outcomes. JAMA 1983; 250: 1721–7.
Ryan, GM, Abdella, TN, McNeeley, SG, Baselski, VS, Drummond, DE. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol 1990; 162: 34–9.
Rastogi, S, Das, B, Salhan, S, Mittal, A. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet 2003; 80: 129–37.
Cohen, I, Veille, JC, Calkins, BM. Improved pregnancy outcome following successful treatment of chlamydial infection. JAMA 1990; 263: 3160–3.
Crombleholme, WR, Schachter, J, Grossman, M, Landers, DV, Sweet, RL. Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol 1990; 75: 752–6.
Alger, LS, Lovchik, JC. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol 1991; 165: 375–81.
Carne, CA, Gibbs, J, Delaney, A, et al. Prevalence, clinical features and quantification of genital non-viral infections. Int J STD AIDS 2013; 24: 273–7.
McKechnie, ML, Hillman, RJ, Jones, R, et al. The prevalence of urogenital micro-organisms detected by a multiplex PCR-reverse line blot assay in women attending three sexual health clinics in Sydney, Australia. J Med Microbiol 2011; 60: 1010–16.
Mobley, VL, Hobbs, MM, Lau, K, et al. Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors. Sex Transm Dis 2012; 39: 706–9.
Watts, DH, Eschenbach, DA, Kenny, GE. Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol 1989; 73: 52–60.
Capoccia, R, Greub, G, Baud, D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis 2013; 26: 231–40.
Braun, P, Lee, YH, Klein, JO, et al. Birth weight and genital mycoplasmas in pregnancy. N Engl J Med 1971; 284: 167–71.
Shurin, PA, Alpert, S, Bernard Rosner, BA, Driscoll, SG, Lee, YH. Chorioamnionitis and colonization of the newborn infant with genital mycoplasmas. N Engl J Med 1975; 293: 5–8.
Kundsin, RB, Driscoll, SG, Monson, RR, et al. Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. N Engl J Med 1984; 310: 941–5.
Hillier, SL, Martius, J, Krohn, M, et al. A case–control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319: 972–8.
Witt, A, Berger, A, Gruber, CJ, et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol 2005; 193: 1663–9.
Harwick, HJ, Purcell, RH, Iuppa, JB, Fekety, FR. Mycoplasma hominis and abortion. J Infect Dis 1970; 121: 260–8.
Tafari, N, Ross, S, Naeye, RL, Judge, DM, Marboe, C. Mycoplasma T strains and perinatal death. Lancet 1976; 1: 108–9.
McCormack, WM, Rosner, B, Lee, YH, Munoz, A, Charles, D, Kass, EH. Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol 1987; 69: 202–7.
Eschenbach, DA, Nugent, RP, Rao, AV, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1991; 164: 734–42.
Workowski, KA, Bolan, GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1–137.
Willcox, RR. International aspects of the venereal diseases and nonvenereal treponematoses. Clin Obstet Gynecol 1975; 18: 207–22.
Centers for Disease Control and Prevention (CDC). Lymphogranuloma venereum among men who have sex with men: Netherlands, 2003–2004. MMWR Morb Mortal Wkly Rep 2004; 53: 985–8.
Kuberski, T. Granuloma inguinale (donovanosis). Sex Transm Dis 1980; 7: 29–36.
Scott, CW, Harper, DM, Jason, RS, Helwig, EB. Neonatal granuloma venereum. AMA Am J Dis Child 1953; 85: 308–15.
Christmas, JT, Wendel, GD, Bawdon, RE, et al. Concomitant infection with Neisseria gonorrhoeae and Chlamydia trachomatis in pregnancy. Obstet Gynecol 1989; 74: 295–8.
Huggins, GR, Preti, G. Vaginal odors and secretions. Clin Obstet Gynecol 1981; 24: 355–77.
Redondo-Lopez, V, Cook, RL, Sobel, JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990; 12: 856–72.
Eschenbach, DA, Davick, PR, Williams, BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989; 27: 251–6.
Fleury, FJ. Adult vaginitis. Clin Obstet Gynecol 1981; 24: 407–38.
Spiegel, CA, Amsel, R, Eschenbach, D, Schoenknecht, F, Holmes, KK. Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 1980; 303: 601–7.
Hillier, SL, Nugent, RP, Eschenbach, DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995; 333: 1737–42.
Minkoff, H, Grunebaum, AN, Schwarz, RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150: 965–72.
Leitich, H, Bodner-Adler, B, Brunbauer, M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003; 189: 139–47.
Watts, DH, Krohn, MA, Hillier, SL, Eschenbach, DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 1990; 75: 52–8.
Guise, JM, Mahon, S, Aickin, M, Helfand, M. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Bacterial Vaginosis in Pregnancy. Rockville, MD: Agency for Healthcare Research and Quality, 2001.
U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148: 214–19.
Bejar, R, Curbelo, V, Davis, C, Gluck, L. Premature labor. II. Bacterial sources of phospholipase. Obstet Gynecol 1981; 57: 479–82.
Amsel, R, Totten, PA, Spiegel, CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14–22.
Nugent, RP, Krohn, MA, Hillier, SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297–301.
Burtin, P, Taddio, A, Ariburnu, O, Einarson, TR, Koren, G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172: 525–9.
Caro-Paton, T, Carvajal, A, Martin de Diego, I, et al. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997; 44: 179–82.
McGregor, JA, French, JI, Jones, W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170: 1048–59.
Joesoef, MR, Hillier, SL, Wiknjosastro, G, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995; 173: 1527–31.
Kurkinen-Raty, M, Vuopala, S, Koskela, M, et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 2000; 107: 1427–32.
Guaschino, S, Ricci, E, Franchi, M, et al. Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur J Obstet Gynecol Reprod Biol 2003; 110: 149–52.
McDonald, HM, O’Loughlin, JA, Vigneswaran, R, Jolley, PT, McDonald, PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol 1994; 84: 343–8.
Carey, JC, Klebanoff, MA, Hauth, JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342: 534–40.
Morales, WJ, Schorr, S, Albritton, J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345–7.
Hauth, JC, Goldenberg, RL, Andrews, WW, DuBard, MB, Copper, RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732–6.
Brocklehurst, P, Gordon, A, Heatley, E, Milan, SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013; (1): CD000262.
McDonald, HM, Brocklehurst, P, Gordon, A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007: (1): CD000262.
Lamont, RF, Jones, BM, Mandal, D, Hay, PE, Sheehan, M. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol 2003; 11: 181–9.
Leitich, H, Brunbauer, M, Bodner-Adler, B, et al. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 2003; 188: 752–8.
Jackel, D, Lai, K. Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilization pregnancy: case report and review. Clin Infect Dis 2013; 56: 555–8.
Diana, A, Epiney, M, Ecoffey, M, Pfister, RE. “White dots on the placenta and red dots on the baby”: congential cutaneous candidiasis – a rare disease of the neonate. Acta Paediatr 2004; 93: 996–9.
Alfei, A, Rizzo, A, Cavanna, C, Lallitto, F, Spinillo, A. Candida glabrata and pre-term premature rupture of membrane complicating in vitro pregnancy: case report and confirmation of mother to neonate transmission. Arch Gynecol Obstet 2014; 290: 211–14.
McLellan, R, Spence, MR, Brockman, M, Raffel, L, Smith, JL. The clinical diagnosis of trichomoniasis. Obstet Gynecol 1982; 60: 30–4.
Block, E. Occurrence of trichomonas in sexual partners of women with trichomoniasis. Acta Obstet Gynecol Scand 1959; 38: 398–403.
Cotch, MF, Pastorek, JG, Nugent, RP, et al. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991; 78: 1087–92.
Lossick, JG, Kent, HL. Trichomoniasis: trends in diagnosis and management. Am J Obstet Gynecol 1991; 165: 1217–22.
Klebanoff, MA, Carey, JC, Hauth, JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487–93.
Kigozi, GG, Brahmbhatt, H, Wabwire-Mangen, F, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003; 189: 1398–400.
Okun, N, Gronau, KA, Hannah, ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005; 105: 857–68.
Yudin, MH, Landers, DV, Meyn, L, Hillier, SL. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003; 102: 527–34.
Jamieson, DJ, Uyeki, TM, Callaghan, WM, Meaney-Delman, D, Rasmussen, SA. What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol 2014; 124: 1005–10.
Meaney-Delman, D, Koonin, LM, Jamieson, DJ. US hospital preparedness for obstetrics patients with possible Ebola. Am J Obstet Gynecol 2015; 212: 417–19.
Dahl, BA, Kinzer, MH, Raghunathan, PL, et al. CDC’s response to the 2014–2016 Ebola epidemic: Guinea, Liberia, and Sierra Leone. MMWR Suppl 2016; 65 (3): 12–20.
Baize, S, Pannetier, D, Oestereich, L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371: 1418–25.
Oduyebo, T, Pineda, D, Lamin, M, et al. A pregnant patient with Ebola virus disease. Obstet Gynecol 2015; 126: 1273–5.
Mupapa, K, Mukundu, W, Bwaka, MA, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis 1999; 179 (Suppl 1): S11–12.
American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 268, February 2002. Management of asymptomatic pregnant or lactating women exposed to anthrax. Obstet Gynecol 2002; 99: 366–8.
Meaney-Delman, D, Zotti, ME, Rasmussen, SA, et al. Anthrax cases in pregnant and postpartum women: a systematic review. Obstet Gynecol 2012; 120: 1439–49.
Meaney-Delman, D, Zotti, ME, Creanga, AA, et al. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis 2014; 20 (2). doi: 10.3201/eid2002.130611.
Meaney-Delman, D, Rasmussen, SA, Beigi, RH, et al. Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol 2013; 122: 885–900.
Fredericks, AC, Fernandez-Sesma, A. The burden of dengue and chikungunya worldwide: implications for the southern United States and California. Ann Glob Health 2014; 80: 466–75.
Johnston, D, Viray, M, Ushiroda, J, et al. Notes from the field: outbreak of locally acquired cases of dengue fever: Hawaii, 2015. MMWR Morb Mortal Wkly Rep 2016; 65 (2): 34–5.
World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: WHO, 2009. http://www.who.int/rpc/guidelines/9789241547871/en/ (accessed March 2017).
Machado, CR, Machado, ES, Rohloff, RD, et al. Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system. PLoS Negl Trop Dis 2013; 7: e2217.
Sinhabahu, VP, Sathananthan, R, Malavige, GN. Perinatal transmission of dengue: a case report. BMC Res Notes 2014; 7: 795.
Pan American Health Organization. Chikungunya: a new virus in the region of the Americas. http://www.paho.org/hq/index.php?option=com_content&view=article&id=9724 (accessed March 2017).
Fritel, X, Rollot, O, Gerardin, P, et al. Chikungunya virus infection during pregnancy, Reunion, France, 2006. Emerg Infect Dis 2010; 16: 418–25.
Ramful, D, Samperiz, S, Fritel, X, et al. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection. J Infect Dis 2014; 209: 1726–30.
Centers for Disease Control and Prevention (CDC). Zika virus. Atlanta, GA: US Department of Health and Human Services, 2016.
Oehler, E, Watrin, L, Larre, P, et al. Zika virus infection complicated by Guillain–Barré syndrome: case report, French Polynesia, December 2013. Euro Surveill 2014; 19 (9): pii: 20720.
American College of Obstetricians and Gynecologists. Interim guidance for the care of obstetric patients during a Zika virus outbreak. Practice Advisory, November 2017.
Besnard, M, Lastere, S, Teissier, A, Cao-Lormeau, V, Musso, D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014; 19 (13): pii: 20751.
Oliveira Melo, AS, Malinger, G, Ximenes, R, et al. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016; 47: 6–7.
Reynolds, MR, Jones, AM, Peterson, EE, et al. Vital signs: update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure: U.S. Zika Pregnancy Registry, 2016. MMWR Morb Mortal Wkly Rep 2017; 66: 366–73.
Brasil, P, Pereira, JP, Moreira, ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Eng J Med 2016; 375: 2321–34.
Centers for Disease Control and Prevention (CDC). Women and their partners trying to become pregnant. www.cdc.gov/pregnancy/zika/women-and-their-partners.html (accessed August 2020).
Centers for Disease Control and Prevention (CDC). Zika Virus: Prevention. Atlanta, GA: US Department of Health and Human Services, 2015.
Centers for Disease Control and Prevention (CDC). West Nile Virus: Insect Repellent Use and Safety. Atlanta, GA: US Department of Health and Human Services, 2015.
Oduyebo, T, Polen, KD, Walke, HT, et al. Update: interim guidance for health care providers caring for pregnant women with possible Zika virus exposure – United States (including U.S. territories), July 2017. MMWR Morb Mortal Wkly Rep 2017; 66: 781–93.
Petersen, EE, Staples, JE, Meaney-Delma, D, et al. Interim guidelines for pregnant women during a Zika virus outbreak: United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65: 30–3.
Centers for Disease Control and Prevention (CDC). Travelers’ health. Zika travel information. http://wwwnc.cdc.gov/travel/page/zika-travel-information (accessed May 2019).
Johns Hopkins University. COVID-19 Dashboard. https://coronavirus.jhu.edu/map.html (accessed November 11, 2020).
Docherty, AB, Harrison, EM, Green, CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterization Protocol: prospective observational cohort study. BMJ 2020; 369: m1985. https://doi.org/10.1136/bmj.m1985.
Wong, SF, Chow, KM, de Swiet, M. Severe acute respiratory syndrome and pregnancy. BJOG 2003; 110: 641–2. https://doi.org/10.1046/j.1471-0528.2003.03008.x.
Asiri, A, Abedi, GD, Al Masri, M, et al. Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia. Clin Infec Dis 2016; 63: 951–3. https://doi.org/10.1093/cid/ciw412.
Public Health England. COVID-19: investigation and initial clinical management of possible cases 2020. www.gov.uk/government/publications/wuhan-novel-coronavirus-initialinvestigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhannovel-coronavirus-wn-cov-infection (accessed March 2, 2020).
Allotey, J, Stallings, E, Bonet, M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370: m3320. https://doi.org/10.1136/bmj.m3320.
Breslin, N, Baptiste, C, Gyamfi-Bannerman, C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020; 2: 100118. https://doi.org/10.1016/j.ajogmf.2020.100118.
ICNARC. Report on COVID-19 in critical care 2020. Updated 25 September 2020. www.icnarc.org/Our-Audit/Audits/Cmp/Reports (accessed September 28, 2020).
Knight, M, Bunch, K, Vousden, N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107. https://doi.org/10.1136/bmj.m2107.
Badr, DA, Mattern, J, Carlin, A, et al. Are clinical outcomes worse for pregnant women at ≥ 20 weeks’ gestation infected with COVID-19? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol 2020; 223: 764–8. https://doi.org/10.1016/j.ajog.2020.07.045.
Savasi, VM, Parisi, F, Patanè, L, et al. Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19). Obstet Gynecol 2020; 136: 252–8. https://doi.org/10.1097/AOG.0000000000003979.
Zambrano, LD, Ellington, S, Strid, P, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status – United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1641–7. https://doi.org/10.15585/mmwr.mm6944e3.
Di Mascio, D, Khalil, A, Saccone, G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2: 100107. https://doi.org/10.1016/j.ajogmf.2020.100107.
Salvatore, CM, Han, JY, Acker, KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health 2020; 4: 721–7. https://doi.org/10.1016/S2352-4642(20)30235-2.
American College of Obstetricians and Gynecologists. Outpatient assessment and management for pregnant women with suspected of confirmed novel coronavirus (COVID-19). www.acog.org/-/media/project/acog/acogorg/files/pdfs/clinical-guidance/practice-advisory/covid-19-algorithm.pdf (accessed July 29, 2020).